After the first year, the average increase in TKV was significantly lower in the intervention group compared to placebo; however, in the third year, this outcome measure did not reach statistical significance.
← all excerpts
Unmet needs and challenges for follow-up and treatment of autosomal dominant polycystic kidney disease: the paediatric perspective.
1
—
—